Publications (last updated 26-11-14)
Total Peer-reviewed Publications = 134 (131 original research articles and 3 review
articles)
Total Senior Author Publications = 19 (as per SFI definition of senior author in 2014;
highlighted below with an asterisk)
134 Frodl T, Skokauskas N, Frey EM, Morris D, Gill M, Carballedo A. BDNF Val66Met
genotype interacts with childhood adversity and influences the formation of
hippocampal subfields. Human Brain Mapping, 35, (12), 2014 p5776-83. PMID:
25044977.
133 Frodl T, Carballedo A, Frey EM, O'Keane V, Skokauskas N, Morris D, Gill M, Hughes
MM, Harkin A, Connor T. Expression of glucocorticoid inducible genes is associated
with reductions in cornu ammonis and dentate gyrus volumes in patients with major
depressive disorder. Developmental Psychopathology. 26, (4pt2), 2014, p1209-1217.
PMID: 25422956.
132 Rose EJ, Morris DW, Fahey C, Cannon D, McDonald C, Scanlon C, Kelly S, Gill M,
Corvin A, Donohoe G. The miR-137 schizophrenia susceptibility variant rs1625579 does
not predict variability in brain volume in a sample of schizophrenic patients and healthy
individuals. American Journal of Medical Genetics B Neuropsychiatric Genetics, 165B,
(6), 2014, p467-71. PMID: 25044277.
131 Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological
insights from 108 schizophrenia-associated genetic loci. Nature, 511, (7510), 2014
p421-7. PMID: 25056061.
130 Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R,
Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini
S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel
K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann O, Binder EB,
Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J,
Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR,
Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty
MM, Chang KD, Ching CR, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G,
Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJ, den Braber A, Delvecchio G,
Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H,
Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S,
Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT,
Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC,
Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur
RE, Gur RC, Göring HH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass
J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra
PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ,
Hulshoff Pol HE, Hwang KS, Jack CR Jr, Jenkinson M, Johnston C, Jönsson EG, Kahn RS,
Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JB,
1
Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard
S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E,
Lourdusamy A, Luciano M, Macciardi F, Machielsen MW, Macqueen GM, Malt UF,
Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal
M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL,
Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses
EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck
M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff
RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z,
Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin
SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman
JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M,
Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L,
Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons
A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM,
Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW,
Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee
NJ, van Eijk K, van Erp TG, van Haren NE, van 't Ent D, van Tol MJ, Valdés Hernández
MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale
ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM,
Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR,
Freimer NB, Lawrence NS, Drevets W; Alzheimer’s Disease Neuroimaging Initiative,
EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group. The
ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic
data. Brain Imaging and Behavior. 8 (2), 2014, p153-82. PMID: 24399358.
129 Mothersill O, Morris DW, Kelly S, Rose EJ, Bokde A, Reilly R, Gill M, Corvin AP,
Donohoe G. Altered medial prefrontal activity during dynamic face processing in
schizophrenia spectrum patients. Schizophrenia Research. [Epub ahead of print]. PMID:
24888525.
128 Nicodemus KK, Hargreaves A, Morris D, Anney R, Gill M, Corvin A, Donohoe G; for
the Schizophrenia Psychiatric Genome-wide Association Study (GWAS) Consortium and
The Wellcome Trust Case Control Consortium 2. Variability in Working Memory
Performance Explained by Epistasis vs Polygenic Scores in the ZNF804A Pathway. JAMA
Psychiatry. [Epub ahead of print]. PMID: 24828433.
127 Kelly S, Morris DW, Mothersill O, Rose EJ, Fahey C, O'Brien C, O'Hanlon E, Gill M,
Corvin AP, Donohoe G. Genome-wide schizophrenia variant at MIR137 does not impact
white matter microstructure in healthy participants. Neuroscience Letters. 574, 2014,
p6-10. PMID: 24820543.
126 McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, Mistry M, Pavlidis P,
Solomon R, Ghiban E, Antoniou E, Kelleher E, O'Brien C, Donohoe G, Gill M, Morris DW,
McCombie WR, Corvin A. De novo mutations in schizophrenia implicate chromatin
remodeling and support a genetic overlap with autism and intellectual disability.
Molecular Psychiatry. 19 (6), 2014, p652-8. PMID: 24776741.
2
* 125 Heron EA, Cormican P, Donohoe G, O'Neill FA, Kendler KS, Riley BP; Wellcome
Trust Case Control Consortium 2, Gill M, Corvin AP, Morris DW. No evidence that runs
of homozygosity are associated with schizophrenia in an Irish genome-wide association
dataset. Schizophrenia Research. 154 (1-3), 2014, p79-82. PMID: 24560374.
124 Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M,
Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P; The
Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work
Groups; The International Multiple Sclerosis Genetics Consortium (IMSGC), McEvoy LK,
Desikan RS, Lie BA, Djurovic S, Dale AM. Genetic pleiotropy between multiple sclerosis
and schizophrenia but not bipolar disorder: differential involvement of immune-related
gene loci. Molecular Psychiatry. [Epub ahead of print]. PMID: 24468824.
123 Rolfe RA, Nowlan NC, Kenny EM, Cormican P, Morris DW, Prendergast PJ, Kelly D,
Murphy P. Identification of mechanosensitive genes during skeletal development:
alteration of genes associated with cytoskeletal rearrangement and cell signalling
pathways. BMC Genomics. 15 (1), 2014, p48. PMID: 24443808.
* 122 Morris DW, Pearson RD, Cormican P, Kenny EM, O'Dushlaine CT, Lemieux
Perreault LP, Giannoulatou E, Tropea D, Maher BS, Wormley B, Kelleher E, Fahey C,
Molinos I, Bellini S, Pirinen M, Strange A, Freeman C, Thiselton DL, Elves RL, Regan R,
Ennis S, Dinan TG, McDonald C, Murphy KC, O'Callaghan E, Waddington JL, Walsh D,
O'Donovan M, Grozeva D, Craddock N, Stone J, Scolnick E, Purcell S, Sklar P, Coe B,
Eichler EE, Ophoff R, Buizer J, Szatkiewicz J, Hultman C, Sullivan P, Gurling H, McQuillin
A, St Clair D, Rees E, Kirov G, Walters J, Blackwood D, Johnstone M, Donohoe G;
International Schizophrenia Consortium; SGENE+ Consortium, O'Neill FA; Wellcome
Trust Case Control Consortium 2, Kendler KS, Gill M, Riley BP, Spencer CC, Corvin A. An
inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor
for psychosis. Human Molecular Genetics, 23 (12), 2014, p3316-26. PMID: 24474471.
121 O'Donoghue T, Morris DW, Fahey C, Da Costa A, Moore S, Cummings E, Leicht G,
Karch S, Hoerold D, Tropea D, Foxe JJ, Gill M, Corvin A, Donohoe G. Effects of ZNF804A
on auditory P300 response in schizophrenia. Translational Psychiatry, 4, 2014, e345.
PMID: 24424391.
* 120 Fahey C, Byrne S, McLaughlin R, Kenna K, Shatunov A, Donohoe G, Gill M, AlChalabi A, Bradley DG, Hardiman O, Corvin AP, Morris DW. Analysis of the
hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish
psychosis case-control sample. Neurobiology of Aging, 35 (6), 2014, p1510.e1-5. PMID:
24411481.
119 Mothersill O, Morris DW, Kelly S, Rose EJ, Fahey C, O'Brien C, Lyne R, Reilly R, Gill
M, Corvin AP, Donohoe G. Effects of MIR137 on fronto-amygdala functional
connectivity. Neuroimage, [Epub ahead of print]. PMID: 24361663.
3
118 Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I,
Sundet K, Christoforou A, Reinvang I, Mukherjee S, Derosse P, Lundervold A, Steen VM,
John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B,
Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe
G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D,
Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK.
Molecular genetic evidence for overlap between general cognitive ability and risk for
schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Molecular
Psychiatry, 19, (2), 2014, p168-74. PMID: 24342994.
117 Rees E, Kirov G, Sanders A, Walters JT, Chambert KD, Shi J, Szatkiewicz J,
O'Dushlaine C, Richards AL, Green EK, Jones I, Davies G, Legge SE, Moran JL, Pato C,
Pato M, Genovese G, Levinson D, Duan J, Moy W, Göring HH, Morris D, Cormican P,
Kendler KS, O'Neill FA, Riley B, Gill M, Corvin A; Wellcome Trust Case Control
Consortium, Craddock N, Sklar P, Hultman C, Sullivan PF, Gejman PV, McCarroll SA,
O'Donovan MC, Owen MJ. Evidence that duplications of 22q11.2 protect against
schizophrenia. Molecular Psychiatry, 19, (1), 2014, p37-40. PMID: 24217254.
116 Rees E, Walters JT, Chambert KD, O'Dushlaine C, Szatkiewicz J, Richards AL,
Georgieva L, Mahoney-Davies G, Legge SE, Moran JL, Genovese G, Levinson D, Morris
DW, Cormican P, Kendler KS, O'Neill FA, Riley B, Gill M, Corvin A; Wellcome Trust Case
Control Consortium, Sklar P, Hultman C, Pato C, Pato M, Sullivan PF, Gejman PV,
McCarroll SA, O'Donovan MC, Owen MJ, Kirov G. CNV analysis in a large schizophrenia
sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and
CGNL1. Human Molecular Genetics, [Epub ahead of print]. PMID: 24163246.
* 115 Kenny EM, Cormican P, Furlong S, Heron E, Kenny G, Fahey C, Kelleher E, Ennis S,
Tropea D, Anney R, Corvin AP, Donohoe G, Gallagher L, Gill M, Morris DW. Excess of
rare novel loss-of-function variants in synaptic genes in schizophrenia and autism
spectrum disorders. Molecular Psychiatry, 19, (8), 2014, p872-9. PMID: 24126926.
114 Corvin A, Morris DW. Genome-wide Association Studies: Findings At The Major
Histocompatibility Complex Locus in Psychosis. Biological Psychiatry, 75, (4), 2014,
p276-83. PMID: 24199664. Review.
113 Rose EJ, Hargreaves A, Morris D, Fahey C, Tropea D, Cummings E, Caltagirone C,
Bossù P, Chiapponi C, Piras F, Spalletta G, Gill M, Corvin A, Donohoe G. Effects of a
genome wide supported schizophrenia risk variant at CNNM2 on brain structure and
attributional style. British Journal of Psychiatry, [Epub ahead of print]. PMID:
24311551.
112 Hargreaves H, Anney R, O’Dushlaine C, Nicodemus KK, The Psychiatric GWAS
Consortium, Gill M, Corvin A, Morris D, Donohoe G. The one and the many: Effects of
the Cell Adhesion Molecule Pathway on Neuropsychological function in Patients with
Psychosis Psychological Medicine. Psychological Medicine, [Epub ahead of print].
PMID: 24284030.
4
111 de Candia TR, Lee SH, Yang J, Browning BL, Gejman PV, Levinson DF, Mowry BJ,
Hewitt JK, Goddard ME, O'Donovan MC, Purcell SM, Posthuma D; International
Schizophrenia Consortium; Molecular Genetics of Schizophrenia Collaboration,
Visscher PM, Wray NR, Keller MC. Additive genetic variation in schizophrenia risk is
shared by populations of African and European descent. American Journal of Human
Genetics, 93, (3), 2013, 463-70. PMID: 23954163.
110 van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn
W, Ripke S; Psychiatric Genome-Wide Association Study (GWAS) Consortium, Ophoff
RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence.
Psychological Medicine, 43, (12), 2013 p2563-70. PMID: 23410598.
109 Ramsay H, Kelleher I, Flannery P, Clarke MC, Lynch F, Harley M, Connor D,
Fitzpatrick C, Morris DW, Cannon M. Relationship between the COMT-Val158Met and
BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an
adolescent general population sample. PLoS ONE, 8, (11), 2013, e79741. PMID:
24224001.
108 Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, Cormican P,
Morris DW, Donaghy CG, Bradley DG, Hardiman O. Delineating the genetic
heterogeneity of ALS using targeted high-throughput sequencing. Journal of Medical
Genetics, 50, (11), 2013, p776-83. PMID: 23881933.
107 Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, BuizerVoskamp JE, Boos HB, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, Kahn RS;
Psychiatric Genome-wide Association Study Consortium. Genetic schizophrenia risk
variants jointly modulate total brain and white matter volume. Biological Psychiatry,
73, (6), 2013, p525-31. PMID: 23039932.
106 Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, Kelsoe JR,
O'Donovan MC, Furberg H; Tobacco and Genetics Consortium; Bipolar Disorder
Psychiatric Genomics Consortium; Schizophrenia Psychiatric Genomics Consortium,
Schork NJ, Andreassen OA, Dale AM. All SNPs are not created equal: genome-wide
association studies reveal a consistent pattern of enrichment among functionally
annotated SNPs. PLoS Genetics, 9, (4), 2013, e1003449. PMID: 23637621.
105 Walters JT, Rujescu D, Franke B, Giegling I, Vásquez AA, Hargreaves A, Russo G,
Morris DW, Hoogman M, Da Costa A, Moskvina V, Fernández G, Gill M, Corvin A,
O'Donovan MC, Donohoe G, Owen MJ. The role of the major histocompatibility
complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
American Journal of Psychiatry, 170, (8), 2013, p877-85. PMID: 23903335.
104 Luo XJ, Li M, Huang L, Steinberg S, Mattheisen M, Liang G, Donohoe G, Shi Y, Chen
C, Yue W, Alkelai A, Lerer B, Li Z, Yi Q, Rietschel M, Cichon S, Collier DA, Tosato S,
Suvisaari J, Rujescu D, Golimbet V, Silagadze T, Durmishi N, Milovancevic MP,
Stefansson H, Schulze TG, Nöthen MM, Chen C, Lyne R, Morris DW, Gill M, Corvin A,
Zhang D, Dong Q, Moyzis RK, Stefansson K, Sigurdsson E, Hu F; MooDS SCZ Consortium,
5
Su B, Gan L. Convergent lines of evidence support CAMKK2 as a schizophrenia
susceptibility gene. Molecular Psychiatry, [Epub ahead of print]. PMID: 23958956.
103 Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler A, Akterin S, Bergen S,
Collins AL, Crowley J, Fromer M, Kim Y, Lee SH, Magnusson PK, Sanchez N, Stahl EA,
Williams S, Wray N, Xia K, Bettella F, Børglum AD, Bulik-Sullivan BK, Cormican P,
Craddock N, de Leeuw C, Durmishi N, Gill M, Golimbet V, Hamshere ML, Holmans P,
Hougaard DM, Kendler KS, Lin K, Morris DW, Mors O, Mortensen PB, Neale B, O'Neill
FA, Owen MJ, Pejovic Milovancevic M, Posthuma D, Powell J, Richards AL, Riley BP,
Ruderfer D, Rujescu D, Sigurdsson E, Silagadze T, Smit AB, Stefansson H, Steinberg S,
Suvisaari J, Tosato S, Walters JT, Verhage M, Multicenter Genetic Studies of
Schizophrenia Consortium, Psychosis Endophenotypes Consortium, Wellcome Trust
Case-Control Consortium2, Bramon E, Corvin AP, O'Donovan MC, Stefansson K, Scolnick
E, Purcell S, McCarroll S, Sklar P, Hultman C, Sullivan PF. Genome-wide association
analysis identifies 14 new risk loci for schizophrenia. Nature Genetics, 45, (10), 2013,
p1150-9. PMID: 23974872.
102 Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic
relationship between five psychiatric disorders estimated from genome-wide SNPs.
Nature Genetics, 45, (9), 2013, p984-94. PMID: 23933821.
101 Rose EJ, Morris DW, Hargreaves A, Fahey C, Greene C, Garavan H, Gill M, Corvin A,
Donohoe G. Neural effects of the CSMD1 genome-wide associated schizophrenia risk
variant rs10504253. American Journal of Medical Genetics B Neuropsychiatric
Genetics, 162, (6), 2013, p530-7. PMID: 23839771.
100 Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC,
Rujescu D, Werge T, van de Bunt M, Morris AP, McCarthy MI; International Consortium
for Blood Pressure GWAS; Diabetes Genetics Replication and Meta-analysis
Consortium; Psychiatric Genomics Consortium Schizophrenia Working Group, Roddey
JC, McEvoy LK, Desikan RS, Dale AM. Improved detection of common variants
associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk
factors. American Journal of Human Genetics, 92, (2), 2013, p197-209. PMID:
23375658.
99 Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller JW,
Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan
PF. Identification of risk loci with shared effects on five major psychiatric disorders: a
genome-wide analysis. Lancet, 381, (9875), 2013, p1371-9. PMID: 23453885.
98 Li M, Luo XJ, Rietschel M, Lewis CM, Mattheisen M, Müller-Myhsok B, Jamain S,
Leboyer M, Landén M, Thompson PM, Cichon S, Nöthen MM, Schulze TG, Sullivan PF,
Bergen SE, Donohoe G, Morris DW, Hargreaves A, Gill M, Corvin A, Hultman C, Toga
AW, Shi L, Lin Q, Shi H, Gan L, Meyer-Lindenberg A, Czamara D, Henry C, Etain B, Bis JC,
Ikram MA, Fornage M, Debette S, Launer LJ, Seshadri S, Erk S, Walter H, Heinz A,
Bellivier F, Stein JL, Medland SE, Vasquez AA, Hibar DP, Franke B, Martin NG, Wright
MJ. Allelic differences between Europeans and Chinese for CREB1 SNPs and their
6
implications in gene expression regulation, hippocampal structure and function, and
bipolar disorder susceptibility. Molecular Psychiatry, 2013. [Epub ahead of print].
PMID: 23670488.
97 Robertson DA, Hargreaves A, Kelleher EB, Morris D, Gill M, Corvin A, Donohoe G.
Social dysfunction in schizophrenia: An investigation of the GAF scale's sensitivity to
deficits in social cognition. Schizophrenia Research, 146, (1-3), 2013, p363-5. PMID:
23422729.
96 Carballedo A, Morris D, Zill P, Fahey C, Reinhold E, Meisenzahl E, Bondy B, Gill M,
Möller HJ, Frodl T. Brain-derived neurotrophic factor Val66Met polymorphism and
early life adversity affect hippocampal volume. American Journal of Medical Genetics
B Neuropsychiatric Genetics, 162B, (2), 2013, p183-90. PMID: 23341118.
* 95 Quinn EM, Cormican P, Kenny EM, Hill M, Anney R, Gill M, Corvin AP, Morris DW.
Development of strategies for SNP detection in RNA-seq data: application to
lymphoblastoid cell lines and evaluation using 1000 Genomes data. PLoS One, 8, (3),
2013, e58815. PMID: 23555596.
94 Guha S, Rees E, Darvasi A, Ivanov D, Ikeda M, Bergen SE, Magnusson PK, Cormican
P, Morris D, Gill M, Cichon S, Rosenfeld JA, Lee A, Gregersen PK, Kane JM, Malhotra AK,
Rietschel M, Nöthen MM, Degenhardt F, Priebe L, Breuer R, Strohmaier J, Psych D,
Ruderfer DM, Moran JL, Chambert KD, Sanders AR, Shi J, Kendler K, Riley B, O'Neill T,
Walsh D, Malhotra D, Corvin A, Purcell S, Sklar P, Iwata N, Hultman CM, Sullivan PF,
Sebat J, McCarthy S, Gejman PV, Levinson DF, Owen MJ, O'Donovan MC, Lencz T, Kirov
G. Implication of a Rare Deletion at Distal 16p11.2 in Schizophrenia. JAMA Psychiatry,
70, (3), 2013, p253-60. PMID: 23325106.
93 Donohoe G, Walters J, Hargreaves A, Rose EJ, Morris DW, Fahey C, Bellini S,
Cummins E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Owen MJ, Gill M, O'Donovan
MC, Tropea D, Rujescu D, Corvin A. Neuropsychological Effects Of The CSMD1 GenomeWide Associated Schizophrenia Risk Variant rs10503253. Genes, Brain, and Behavior,
12, (2), 2013, p203-9. PMID: 23320435.
92 Cummings E, Donohoe G, Hargreaves A, Moore S, Fahey C, Dinan TG, McDonald C,
O'Callaghan E, O'Neill FA, Waddington JL, Murphy KC, Morris DW, Gill M, Corvin A,
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the
novel schizophrenia risk variant at MIR-137. Neuroscience Letters, 532, 2013, p33-8.
PMID: 22982201.
91 Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D, Jones I, Forty L,
Jones L, Gordon-Smith K, Riley B, O'Neill T, Kendler KS, Sklar P, Purcell S, Kranz J; The
Schizophrenia Psychiatric Genome-wide Association Study Consortium (PGC),
Wellcome Trust Case Control Consortium+ (WTCCC+), Wellcome Trust Case Control
Consortium 2 (WTCCC2), Morris D, Gill M, Holmans P, Craddock N, Corvin A, Owen MJ,
O'Donovan MC. Genome-wide significant associations in schizophrenia to ITIH3/4,
7
CACNA1C and SDCCAG8, and extensive replication of associations reported by the
Schizophrenia PGC. Molecular Psychiatry, 18, (6), 2013, p708-12. PMID: 22614287.
90 Jia P, Wang L, Fanous AH, Pato CN, Edwards TL; International Schizophrenia
Consortium***, Zhao Z. Network-assisted investigation of combined causal signals
from genome-wide association studies in schizophrenia. PLoS Computational Biology.
8, (7), 2012, e1002587. PMID: 22792057.
89 Strange A, Riley BP, Spencer CA, Morris DW, Pirinen M, O'Dushlaine CT, Su Z, Maher
BS, Freeman C, Cormican P, Bellenguez C, Kenny EM, Band G, Wormley B, Donohoe G,
Dilthey A, Moutsianas L, Quinn E, Edkins S, Judge R, Coleman K, Hunt S, Tropea D,
Roche S, Cummings L, Kelleher E, McKeon P, Dinan T, McDonald C, Murphy KC,
O'Callaghan E, O'Neill FA, Waddington JL, Walsh D, Giannoulatou E, Langford C,
Deloukas P, Gray E, Dronov S, Potter S, Pearson R, Vukcevic D, Tashakkori-Ghanbaria A,
Blackwell JM,15, Bramon E, Brown MA, Casas JP, Duncanson A, Jankowski J, Markus HS,
Mathew CG, Palmer CNA, Plomin RP, Rautanen A, Sawcer SJ, Trembath RC,
Viswanathan AC, Wood NW, Stone J, Scolnick E, Purcell S, Sklar P, SGENE+ Consortium,
Ripke S, Walters J, Owen MJ, O'Donovan MC, Schizophrenia Working Group of the
Psychiatric GWAS Consortium, Peltonen L, McVean G, Kendler KS, Gill M, Donnelly P,
Corvin A for Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case
Control Consortium 2. Genome-wide association study implicates HLA-C*01:02 as a risk
factor at the major histocompatibility complex locus in schizophrenia. Biological
Psychiatry, 72, (8), 2012, p620-8. PMID: 22883433.
88 Donohoe G, Duignan A, Hargreaves A, Morris DW, Rose E, Robertson D, Cummings
E, Moore S, Gill M, Corvin A, Social cognition in bipolar disorder versus schizophrenia:
comparability in mental state decoding deficits. Bipolar Disorders, 14, (7), 2012, p7438. PMID: 23020773.
87 Murphy ML, Carballedo A, Fagan AJ, Morris D, Fahey C, Meaney J, Frodl T,
Neurotrophic tyrosine kinase polymorphism impacts white matter connections in
patients with major depressive disorder. Biological Psychiatry, 72, (8), 2012, p663-70.
PMID: 22609366.
86 Jia P, Wang L, Fanous AH, Chen X, Kendler KS, International Schizophrenia
Consortium, Zhao Z. A bias-reducing pathway enrichment analysis of genome-wide
association data confirmed association of the MHC region with schizophrenia. Journal
of Medical Genetics, 49, (2), 2012, p96-103. PMID: 22187495.
85 Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A,
Frodl T. Reduced fractional anisotropy in the uncinate fasciculus in patients with major
depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor
genotype. American Journal of Medical Genetics B Neuropsychiatric Genetics, 159B,
(5), 2012, p537-48. PMID: 22585743.
84 Delaney C, McGrane J, Cummings E, Morris DW, Tropea D, Gill M, Corvin A,
Donohoe G. Preserved cognitive function is associated with suicidal ideation and single
8
suicide attempts in schizophrenia. Schizophrenia Research, 140, (1-3), 2012, p232-6.
PMID: 22796150.
83 Bermingham R, Carballedo A, Lisiecka D, Fagan A, Morris D, Fahey C, Donohoe G,
Meaney J, Gill M, Frodl T. Effect of Genetic Variant in BICC1 on Functional and
Structural Brain Changes in Depression. Neuropsychopharmacology, 37, (13), 2012,
p2855-62. PMID: 22910460.
82 Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen
OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G,
Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J,
Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E; GROUP, Hougaard DM,
Orntoft T, Didriksen M, Hollegaard MV, Nordentoft M, Abramova L, Kaleda V, Arrojo M,
Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni
V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney LA, Franke B, van den
Berg LH, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H,
Freitag CM, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I,
Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N,
Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N,
Surguladze S, Vincent JB, Farmer A, Mitchell PB, Wright A, Schofield PR, Fullerton JM,
Montgomery GW, Martin NG, Rubino IA, van Winkel R, Kenis G, De Hert M, Réthelyi
JM, Bitter I, Terenius L, Jönsson EG, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon
E, Powell J, Murray R, Corvin A, Gill M, Morris D, O'Neill FA, Kendler K, Riley B;
Wellcome Trust Case Control Consortium 2, Craddock N, Owen MJ, O'Donovan MC,
Thorsteinsdottir U, Kong A, Ehrenreich H, Carracedo A, Golimbet V, Andreassen OA,
Børglum AD, Mors O, Mortensen PB, Werge T, Ophoff RA, Nöthen MM, Rietschel M,
Cichon S, Ruggeri M, Tosato S, Palotie A, St Clair D, Rujescu D, Collier DA, Stefansson H,
Stefansson K. Common variant at 16p11.2 conferring risk of psychosis. Molecular
Psychiatry, 2012, [Epub ahead of print] PMID: 23164818.
81 Rose EJ, Morris DW, Fahey C, Robertson IH, Greene C, O'Doherty J, Newell FN,
Garavan H, McGrath J, Bokde A, Tropea D, Gill M, Corvin AP, Donohoe G. The effect of
the neurogranin schizophrenia risk variant rs12807809 on brain structure and function.
Twin Research and Human Genetics, 15, (3), 2012, p296-303. PMID: 22856365.
80 Connell S, Meade KG, Allan B, Lloyd AT, Kenny E, Cormican P, Morris DW, Bradley
DG, O'Farrelly C. Avian resistance to Campylobacter jejuni colonization is associated
with an intestinal immunogene expression signature identified by mRNA sequencing.
PLoS One, 7, (8), 2012, e40409. PMID: 22870198.
79 Foley C, Chapwanya A, Creevey C, Narciandi F, Morris D, Kenny E, Cormican P,
Callanan JJ, O'Farrelly C, Meade KG. Global endometrial transcriptomic profiling:
transient immune activation precedes tissue proliferation and repair in healthy beef
cows. BMC Genomics, 13, (1), 2012, 489. PMID: 22985206.
78 Derks EM, Vorstman JA, Ripke S, Kahn RS, Schizophrenia Psychiatric Genomic
Consortium, Ophoff RA. Investigation of the genetic association between quantitative
9
measures of psychosis and schizophrenia: a polygenic risk score analysis. PloS One, 7,
(6), 2012, e37852. PMID: 22761660.
77 Corvin AP, Molinos I, Little G, Donohoe G, Gill M, Morris DW, Tropea D. Insulin-like
growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of
synaptic markers in neuronal circuits through different cellular mechanisms.
Neuroscience Letters, 520, (1), 2012, p51-56. PMID: 22609570.
76 Keller MC, Simonson MA, Ripke S, Neale BM, Gejman PV, Howrigan DP, Lee SH,
Lencz T, Levinson DF, Sullivan PF, Schizophrenia Psychiatric Genome-Wide Association
Study Consortium. Runs of homozygosity implicate autozygosity as a schizophrenia risk
factor. PLoS Genetics, 8, (4), 2012, e1002656. PMID: 22511889.
75 Lee SH, Decandia TR, Ripke S, Yang J, Schizophrenia Psychiatric Genome-Wide
Association Study Consortium (PGC-SCZ), International Schizophrenia Consortium***,
Molecular Genetics of Schizophrenia Collaboration (MGS), Sullivan PF, Goddard ME,
Keller MC, Visscher PM, Wray NR. Estimating the proportion of variation in
susceptibility to schizophrenia captured by common SNPs. Nature Genetics, 44, (3),
2012, p247-250. PMID: 22344220.
74 Richards AL, Jones L, Moskvina V, Kirov G, Gejman PV, Levinson DF, Sanders AR;
Molecular Genetics of Schizophrenia Collaboration (MGS); International Schizophrenia
Consortium*** (ISC), Purcell S, Visscher PM, Craddock N, Owen MJ, Holmans P,
O'Donovan MC. Schizophrenia susceptibility alleles are enriched for alleles that affect
gene expression in adult human brain. Molecular Psychiatry, 17, (2), 2012, p193-201.
PMID: 21339752.
* 73 Gilks WP, Hill M, Gill M, Donohoe G, Corvin AP, Morris DW. Functional
investigation of a schizophrenia GWAS signal at the CDC42 gene. World Journal of
Biological Psychiatry, 13, (7), 2012, p550-4. PMID: 22385474.
72 Collins AL, Kim Y, Sklar P, International Schizophrenia Consortium, O'Donovan MC,
Sullivan PF. Hypothesis-driven candidate genes for schizophrenia compared to genomewide association results. Psychological Medicine, 2012, 42, p607-616. PMID:
21854684.
71 Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel
K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM,
Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ,
Langan C, Lopez LM, Hansell NK, Hwang KS, Kim S, Laje G, Lee PH, Liu X, Loth E,
Lourdusamy A, Mattingsdal M, Mohnke S, Maniega SM, Nho K, Nugent AC, O'Brien C,
Papmeyer M, Pütz B, Ramasamy A, Rasmussen J, Rijpkema M, Risacher SL, Roddey JC,
Rose EJ, Ryten M, Shen L, Sprooten E, Strengman E, Teumer A, Trabzuni D, Turner J, van
Eijk K, van Erp TG, van Tol MJ, Wittfeld K, Wolf C, Woudstra S, Aleman A, Alhusaini S,
Almasy L, Binder EB, Brohawn DG, Cantor RM, Carless MA, Corvin A, Czisch M, Curran
JE, Davies G, de Almeida MA, Delanty N, Depondt C, Duggirala R, Dyer TD, Erk S,
Fagerness J, Fox PT, Freimer NB, Gill M, Göring HH, Hagler DJ, Hoehn D, Holsboer F,
10
Hoogman M, Hosten N, Jahanshad N, Johnson MP, Kasperaviciute D, Kent JW Jr,
Kochunov P, Lancaster JL, Lawrie SM, Liewald DC, Mandl R, Matarin M, Mattheisen M,
Meisenzahl E, Melle I, Moses EK, Mühleisen TW, Nauck M, Nöthen MM, Olvera RL,
Pandolfo M, Pike GB, Puls R, Reinvang I, Rentería ME, Rietschel M, Roffman JL, Royle
NA, Rujescu D, Savitz J, Schnack HG, Schnell K, Seiferth N, Smith C, Steen VM, Valdés
Hernández MC, Van den Heuvel M, van der Wee NJ, Van Haren NE, Veltman JA, Völzke
H, Walker R, Westlye LT, Whelan CD, Agartz I, Boomsma DI, Cavalleri GL, Dale AM,
Djurovic S, Drevets WC, Hagoort P, Hall J, Heinz A, Jack CR Jr, Foroud TM, Le Hellard S,
Macciardi F, Montgomery GW, Poline JB, Porteous DJ, Sisodiya SM, Starr JM, Sussmann
J, Toga AW, Veltman DJ, Walter H, Weiner MW; Alzheimer's Disease Neuroimaging
Initiative; EPIGEN Consortium; IMAGEN Consortium; Saguenay Youth Study Group, Bis
JC, Ikram MA, Smith AV, Gudnason V, Tzourio C, Vernooij MW, Launer LJ, DeCarli C,
Seshadri S; Cohorts for Heart and Aging Research in Genomic Epidemiology
Consortium, Andreassen OA, Apostolova LG, Bastin ME, Blangero J, Brunner HG,
Buckner RL, Cichon S, Coppola G, de Zubicaray GI, Deary IJ, Donohoe G, de Geus EJ,
Espeseth T, Fernández G, Glahn DC, Grabe HJ, Hardy J, Hulshoff Pol HE, Jenkinson M,
Kahn RS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meyer-Lindenberg A,
Morris DW, Müller-Myhsok B, Nichols TE, Ophoff RA, Paus T, Pausova Z, Penninx BW,
Potkin SG, Sämann PG, Saykin AJ, Schumann G, Smoller JW, Wardlaw JM, Weale ME,
Martin NG, Franke B, Wright MJ, Thompson PM; Enhancing Neuro Imaging Genetics
through Meta-Analysis (ENIGMA) Consortium. Identification of common variants
associated with human hippocampal and intracranial volumes. Nature Genetics, 44,
(5), 2012, p552-561. PMID: 22504417.
70 Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S,
O’Doherty J, Newell FN, McGrath J, Bodke A, Garavan H, Frodl T, Gill M, Corvin AP,
Donohoe G. The NOS1 variant rs6490121 is associated with variation in prefrontal
function and gray matter density in healthy individuals. Neuroimage, 60, (1), 2012,
p614-622. PMID: 22227051.
69 Hargreaves A, Morris DW, Rose E, Fahey C, Moore S, Cummings E, Tropea D, Gill M,
Corvin A, Donohoe G. ZNF804A and social cognition in patients with schizophrenia and
healthy controls. Molecular Psychiatry, 17, (2), 2012, p118-119. PMID: 21876541.
68 Badner JA, Koller D, Foroud T, Edenberg H, Numberger JI, Sandi PP, Willour VL,
McMahon FJ, Potash JB, Hamshere M, Grozeva D, Green E, Kirov G, Jones I, Jones L,
Craddock N, Morris D, Segurado R, Gill M, Sadovnick D, Remick R, Keck P, Kelso J, Ayub
M, Maclean A, Blackwood D, Liu CY, Gershon ES, McMahon W, Lyon GJ, Robinson R,
Ross J, Byerley W. Genome-wide linkage analysis of 972 bipolar pedigrees using singlenucleotide polymorphisms. Molecular Psychiatry, 17, (8), 2012, p818-826. PMID:
21769101.
67 O'Donoghue T, Morris DW, Fahey C, Costa AD, Foxe JJ, Hoerold D, Tropea D, Gill M,
Corvin A, Donohoe G. A NOS1 variant implicated in cognitive performance influences
evoked neural responses during a high density EEG study of early visual perception.
Human Brain Mapping, 33, (5), 2012, p1202-1211. PMID: 21520349.
11
66 Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM; International Schizophrenia
Consortium, Holmans PA, O'Donovan MC, Purcell SM, Smit AB, Verhage M, Sullivan PF,
Visscher PM, Posthuma D.Functional gene group analysis identifies synaptic gene
groups as risk factor for schizophrenia. Molecular Psychiatry, 17, (10), 2012, p9961006. PMID: 21931320.
65 Jablensky A, Angelicheva D, Donohoe GJ, Cruickshank M, Azmanov DN, Morris DW,
McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B,
Verbrugghe PL, Filipovska A, Rackham O, Bishop AR, Rasmussen KO, Dragovic M,
Cooper M, Phillips M, Badcock J, Bramon-Bosch E, Almeida OP, Flicker L, Gill M, Corvin
A, Macgregor S, Kalaydjieva L. Promoter polymorphisms in two overlapping 6p25 genes
implicate mitochondrial proteins in cognitive deficit in schizophrenia. Molecular
Psychiatry, 17, (12), 2012, p1328-39. PMID: 21968932.
64 Chen J, Lee G, Fanous AH, Zhao Z, Jia P, O'Neill A, Walsh D, Kendler KS, Chen X,
International Schizophrenia Consortium. Two non-synonymous markers in PTPN21,
identified by genome-wide association study data-mining and replication, are
associated with schizophrenia. Schizophrenia Research, 131, (1-3), 2011, p43-51. PMID:
21752600.
63 Fitzpatrick DA, O'Brien J, Moran C, Hasin N, Kenny E, Cormican P, Gates A, Morris
DW, Jones GW. Assessment of Inactivating Stop Codon Mutations in Forty
Saccharomyces cerevisiae Strains: Implications for [PSI] Prion- Mediated Phenotypes.
PLoS One, 6, (12), 2011, e28684. PMID: 22194885.
62 Rünker AE, O'Tuathaigh C, Dunleavy M, Morris DW, Little GE, Corvin AP, Gill M,
Henshall DC, Waddington JL, Mitchell KJ. Mutation of Semaphorin-6A Disrupts Limbic
and Cortical Connectivity and Models Neurodevelopmental Psychopathology. PLoS
One, 6, (11), 2011, e26488. PMID: 22132072.
61 Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium.
Genome-wide association study identifies five new schizophrenia loci. Nature Genetics,
43, (10), 2011, p969-976. PMID: 21926974.
60 Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale
genome-wide association analysis of bipolar disorder identifies a new susceptibility
locus near ODZ4. Nature Genetics, 43, (10), 2011, p 977-983. PMID: 21926972.
* 59 Dagdan E, Morris DW, Campbell M, Hill M, Rothermundt M, Kastner F, Hofoff C,
Von Eiff C, Krakowitzky P, Gill M, McKeon P, Roche S. Functional assessment of a
promoter polymorphism in S100B, a putative risk variant for bipolar disorder. American
Journal of Medical Genetics B Neuropsychiatric Genetics, 156, (6), 2011, p691-699.
PMID: 21714070.
58 Hill MJ, Kenny E, Roche S, Morris DW, Corvin A, Hawi Z, Gill M, Anney RJ. Allelic
expression imbalance of the schizophrenia susceptibility gene CHI3L1: evidence of cis-
12
acting variation and tissue specific variation. Psychiatric Genetics, 21, (6), 2011, p281286. PMID: 21642896.
57 Bridges M, Heron E, O'Dushlaine, Segurado R, The International Schizophrenia
Consortium (ISC), Morris DW, Corvin A, Gill M, Pinto C. Genetic Classification of
Populations using Supervised Learning. PLoS One, 6, (5), 2011. PMID: 21589856.
56 Casey J, Kawaguchi R, Morrissey M, Sun H, McGettigan P, Nielsen JE, Conroy J,
Regan R, Kenny E, Cormican P, Morris DW, Tormey P, Ní Chróinín M, Kennedy BN,
Lynch S, Green A, Ennis S. First implication of STRA6 mutations in isolated
anophthalmia, microphthalmia, and coloboma: A new dimension to the STRA6
phenotype. Human Mutation, 32, (12), 2011, p1417-1426. PMID: 21901792.
55 Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon
S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters
V, Welsh DK, Craig D, Kelsoe JR, Gershon ES, Leal SM, Aquila MD, Morris DW, Gill M,
Corvin A, Insel PA, McClellan J, King MC, Karayiorgou M, Levy DL, DeLisi LE, Sebat J.
Duplications of the neuropeptide receptor VIPR2 confer significant risk for
schizophrenia. Nature, 471, (7339), 2011, p499-503. PMID: 21346763.
* 54 Kenny EM, Cormican P, Gilks WP, Gates AS, O’Dushlaine CT, Pinto C, Corvin AP,
Gill M, Morris DW. Multiplex target enrichment using DNA indexing for ultra-high
throughput SNP detection. DNA Research, 18, (1), 2011, p31-38. PMID: 21163834.
53 Donohoe G, Walters J, Morris DW, Da Costa A, Rose E, Hargreaves A, Maher K,
Hayes E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Moskvina V, Owen MJ,
O'Donovan MC, Gill M, Corvin A, Rujescu D. A neuropsychological investigation of the
genome wide associated schizophrenia risk variant NRGN rs12807809. Schizophrenia
Research, 125, (2-3), 2011, p304-6. PMID: 21112188.
52 Donohoe G, Rose E, Frodl T, Morris D, Spoletini I, Adriano F, Bernardini S,
Caltagirone C, Bossù P, Gill M, Corvin AP and Spalletta G. ZNF804A risk allele is
associated with relatively intact gray matter volume in patients with schizophrenia.
Neuroimage, 54, (3), 2011, p2132-7. PMID: 20934520.
51 Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, Georgieva L,
Williams NM, Morris DW, Quinn EM, Giegling I, Ikeda M, Wood J, Lencz T, Hultman C,
Lichtenstein P, Thiselton D, Maher BS, Molecular Genetics of Schizophrenia
Collaboration (MGS), International Schizophrenia Consortium (ISC), SGENE-plus
GROUP, Malhotra AK, Riley B, Kendler KS, Gill M, Sullivan P, Sklar P, Purcell S,
Nimgaonkar VL, Kirov G, Holmans P, Corvin A, Rujescu D, Craddock N, Owen MJ,
O'Donovan MC. Fine mapping of ZNF804A and genome-wide significant evidence for its
involvement in schizophrenia and bipolar disorder. Molecular Psychiatry, 16, (4), 2011,
p429-41. PMID: 20368704.
50 O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, International
Schizophrenia Consortium, Corvin A. Molecular pathways involved in neuronal cell
13
adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder
susceptibility. Molecular Psychiatry, 16, (3), 2011, p286-292. PMID: 20157312.
49 Chen X, Lee G, Maher BS, Fanous AH, Chen J, Zhao Z, Guo A, van den Oord E,
Sullivan PF, Shi J, Levinson DF, Gejman PV, Sanders A, Duan J, Owen MJ, Craddock NJ,
O'Donovan MC, Blackman J, Lewis D, Kirov GK, Qin W, Schwab S, Wildenauer D,
Chowdari K, Nimgaonkar V, Straub RE, Weinberger DR, O'Neill FA, Walsh D, Bronstein
M, Darvasi A, Lencz T, Malhotra AK, Rujescu D, Giegling I, Werge T, Hansen T, Ingason
A, Nöethen MM, Rietschel M, Cichon S, Djurovic S, Andreassen OA, Cantor RM, Ophoff
R, Corvin A, Morris DW, Gill M, Pato CN, Pato MT, Macedo A, Gurling HM, McQuillin A,
Pimm J, Hultman C, Lichtenstein P, Sklar P, Purcell SM, Scolnick E, St Clair D, Blackwood
DH, Kendler KS. GWA study data mining and independent replication identify
cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular
Psychiatry, 16, (11), 2011, p1117-1129. PMID: 20838396.
48 Raychaudhuri S, Korn JM, McCarroll SA, International Schizophrenia Consortium**,
Altshuler D, Sklar P, Purcell S, Daly MJ. Accurately assessing the risk of schizophrenia
conferred by rare copy-number variation affecting genes with brain function. PLoS
Genetics, 6, (9), 2010, e1001097. PMID: 20838587.
47 Donohoe G, Morris DW, Corvin A. The Psychosis Susceptibility gene ZNF804A:
associations, functions and phenotypes. Schizophrenia Bulletin, 36, (5), 2010, p904909. PMID: 20688871. Review.
46 O'Dushlaine CT, Morris DW, Moskvina V, Kirov G, International Schizophrenia
Consortium, Gill M, Corvin A, Wilson JF, Cavalleri GL. Population structure and genomewide patters of variation in Ireland and Britain. European Journal of Human Genetics,
18, (11), 2010, p1248-1254. PMID: 20571510.
45 Moskvina V, Smith M, Ivanov D, Blackwood D, Stclair D, Hultman C, Toncheva D, Gill
M, Corvin A, O'Dushlaine C, Morris DW, Wray NR, Sullivan P, Pato C, Pato MT, Sklar P,
Purcell S, Holmans P, O'Donovan MC, Owen MJ, Kirov G. Genetic Differences between
Five European Populations. Human Heredity, 70, (2), 2010, p141-149. PMID: 20616560.
44 Cummings E, Donohoe G, Morris DW, Gill M, Corvin A. Clinical symptomatology and
the psychosis risk gene, ZNF804A. Schizophrenia Research, 122, (1-3), 2010, p273-275.
PMID: 20538430.
43 Spalletta G, Morris DW, Angelucci F, Rubino IA, Spoletini I, Bria P, Martinotti G,
Siracusano A, Bonaviri G, Bernadini S, Caltagirone C, Bossu P, Donohoe G, Gill M, Corvin
AP. BDNF Val66 Met polymorphism is associated with aggressive behaviour in
schizophrenia. European Psychiatry, 25, (6), 2010, p311-313. PMID: 20430595.
* 42 Quinn EM, Hill M, Anney R, Gill M, Corvin AP, Morris DW. Evidence for cis-acting
regulation of ANK3 and CACNA1C gene expression. Bipolar Disorders, 12, (4), 2010,
p440-445. PMID: 20636642.
14
41 Walters JTR, Corvin A, Williams H, Dragovic M, Quinn EM, Judge R, Smith DJ, Norton
N, Giegling I, Hartmann AM, Möller HJ, Muglia P, Moskvina V, O’Donoghue T, Morar M,
Cooper M, Chandler D, Jablensky A, Gill M, Owen MJ, Kaladjieva L, Morris DW,
O’Donovan MC, Rujescu D, Donohoe G. The psychosis susceptibility gene ZNF804A is
associated with less impaired cognitive performance in schizophrenia. Archives of
General Psychiatry, 67, (7), 2010, p692-700. PMID: 20603450.
* 40 Gilks WP, Allott EH, Donohoe G, Cummings E, International Schizophrenia
Consortium, Gill M, Corvin AP, Morris DW. Replicated genetic evidence supports a role
for HOMER2 in schizophrenia. Neuroscience Letters, 468, (3), 2010, p229 - 233. PMID:
19914345.
39 Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C,
Bossù P, McDonald C, Gill M, Corvin AP, Spalletta G. Reduced Occipital and Prefrontal
Brain Volumes in Dysbindin-Associated Schizophrenia. Neuropsychopharmacology, 35,
(2), 2010, p368 - 373. PMID: 19794403.
38 Carroll LS, Williams NM, Moskvina V, Russell E, Norton N, Williams HJ, Peirce T,
Georgieva , Dwyer S, Grozeva D, Greene E, Farmer A, McGuffin P, Morris DW, Corvin A,
Gill M, Rujescu D, Sham P, Holmans P, Jones I, Kirov G, Craddock N, O’Donovan MC,
Owen MJ. Evidence for rate and common genetic risk variants for schizophrenia at a
protein kinase C, alpha. Molecular Psychiatry, 15, (11), 2010, p1101 – 1111. PMID:
19786960.
37 O'Dushlaine C, Kenny E, Heron EA, Segurado R, Gill M, Morris DW, Corvin A. The
SNP ratio test: pathway analysis of genome-wide association datasets. Bioinformatics,
25, (20), 2009, p2762 – 2763. PMID: 19620097.
36 Donohoe G, Walters J, Morris DW, Quinn EM, Judge R, Norton N, Giegling I,
Hartmann AM, Möller HJ, Muglia P, Williams H, Moskvina V, Peel R, O’Donoghue T,
Owen MJ, O’Donovan MC, Gill M, Rujescu, D, Corvin A. NOS1 influences verbal
intelligence and working memory in both patients with schizophrenia and healthy
controls. Archives of General Psychiatry, 66, (10), 2009, p1045 - 1054. PMID:
19805695.
35
International Schizophrenia Consortium***. Common polygenic variation
contributes to risk of schizophrenia and bipolar disorder. Nature, 460, (7256), 2009,
p748 - 752. PMID: 19571811.
34 Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, International Schizophrenia
Consortium***, Purcell SM, Sklar P, Scolnick EM, Xavier RJ, Altshuler D, Daly MJ.
Identifying relationships among genomic disease regions: predicting genes at
pathogenic SNP associations and rare deletions. PLoS Genetics, 5, (6), 2009, e1000534.
PMID: 19557189.
33 Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P,
International Schizophrenia Consortium***, Wellcome Trust Case Control Consortium,
15
Craddock N, Owen MJ, O'Donovan MC. Support for the involvement of large copy
number variants in the pathogenesis of schizophrenia. Human Molecular Genetics, 18,
(8), 2009, p1497 – 1503. PMID: 19181681.
32 O'Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M,
Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung
HT, Giegling I, Hartmann AM, Möller HJ, Morris DW, Shi Y, Feng G, Hoffmann P,
Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM,
Schulze TG, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan J, Sanders AR, Levinson
DF, Adolfsson R, Osby U, Terenius L, Jönsson EG, Cichon S, Nöthen MM, Gill M, Corvin
AP, Rujescu D, Gejman PV, Kirov G, Craddock N, Williams NM, Owen MJ. Analysis of 10
independent samples provides evidence for association between schizophrenia and a
SNP flanking fibroblast growth factor receptor 2. Molecular Psychiatry, 14, (1), 2009,
p30 - 36. PMID: 18813210.
31 O'Gráda C, Barry S, McGlade N, Behan C, Haq F, Hayden J, O'Donoghue T, Peel R,
Morris DW, O'Callaghan E, Gill M, Corvin AP, Dinan TG, Donohoe G. Does the ability to
sustain attention underlie symptom severity in schizophrenia? Schizophrenia Research,
107, (2-3), 2009, p319 – 323. PMID: 18768299.
30 International Schizophrenia Consortium***. Rare chromosomal deletions and
duplications increase risk of schizophrenia. Nature, 455, (7210), 2008, p237 – 241.
PMID: 18668038.
29 Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov
G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K,
Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J,
Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill
M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, Macintyre DJ, Maclean
AW, St Clair D, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A,
Collier DA, Bass NJ, Young AH, Lawrence J, Nicol Ferrier I, Anjorin A, Farmer A, Curtis D,
Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH; Wellcome
Trust Case Control Consortium, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N.
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C
in bipolar disorder. Nature Genetics, 40, (9), 2008, p1056 – 1058. PMID: 18711365.
28 O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I,
Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC,
Howie B, Leung HT, Hartmann AM, Möller HJ, Morris DW, Shi Y, Feng G, Hoffmann P,
Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM,
Schulze TG, Williams NM, Giegling I, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan
J, Sanders AR, Levinson DF, Gejman PV; Molecular Genetics of Schizophrenia
Collaboration, Gejman PV, Sanders AR, Duan J, Levinson DF, Buccola NG, Mowry BJ,
Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Cloninger CR, Cichon S,
Nöthen MM, Gill M, Corvin A, Rujescu D, Kirov G, Owen MJ. Identification of loci
associated with schizophrenia by genome-wide association and follow-up. Nature
Genetics, 40, (9), 2008, p1053 – 1055. PMID: 18677311.
16
27 Anney RJ, Kenny E, O'Dushlaine CT, Lasky-Su J, Franke B, Morris DW, Neale BM,
Asherson P, Faraone SV, Gill M. Non-random error in genotype calling procedures:
Implications for family-based and case-control genome-wide association studies.,
American Journal of Medical Genetics B Neuropsychiatric Genetics, 147 B, (8), 2008,
p1379 – 1386. PMID: 18663727.
26 O'Dushlaine CT, Dolan C, Weale ME, Stanton A, Croke DT, Kalviainen R, Eriksson K,
Kantanen AM, Gibson RA, Hosford D, Sisodiya SM, Gill M, Corvin AP, Morris DW,
Delanty N, Cavalleri GL. An assessment of the Irish population for large-scale genetic
mapping studies involving epilepsy and other complex diseases. European Journal of
Human Genetics, 16, (2), 2008, p176 – 183. PMID: 17971835.
25 Corvin A, Donohoe G, Nangle JM, Schwaiger S, Morris D, Gill M. A dysbindin risk
haplotype associated with less severe manic-type symptoms in psychosis. Neuroscience
Letters, 431, (2), 2008, p146 – 149. PMID: 18162312.
* 24 Yang MS, Morris DW**, Kenny E, O’Dushalaine CT, Schwaiger S, Nangle, JM,
Clarke S, Scully P, Quinn J, Meagher D, Baldwin P, Crumlish N, O’Callaghan E,
Waddington JL, Gill M, Corvin A, Chitinase-3-Like1 (CHI3L1) Gene and Schizophrenia:
Genetic Association and a Potential functional Mechanism. Biological Psychiatry, 64,
(2), 2008, p98 – 103. PMID: 18281018.
23 Donohoe G, Morris DW, De Sanctis P, Magno E, Montesi J, Garavan H, Robertson I,
Javitt D, Gill M, Corvin A, Fox J. Early Visual Processing Deficits in Dysbindin-Associated
Schizophrenia. Biological Psychiatry, 63, (5), 2008, p484 – 489. PMID: 17945199.
* 22 Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S, Nangle JM,
Donohoe G, Clarke S, Scully P, Quinn J, Meagher D, Baldwin P, Crumlish N, O’Callaghan
E, Waddington JL, Gill M, Corvin AP. Dysbindin (DTNBP1) and the BLOC-1 protein
complex: main and epistatic gene effects are potential contributors to schizophrenia
susceptibility. Biological Psychiatry, 63, (1), 2008, p24 – 31. PMID: 17618940.
21 Corvin A, Donohoe G, McGhee K, Murphy K, Kenny N, Schwaiger S, Nangle JM,
Morris D, Gill M. D-amino acid oxidase (DAO) genotype and mood symptomatology in
schizophrenia. Neuroscience Letters, 426, (2), 2007, p97 – 100. PMID: 17890006.
20 Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A, Becker N, de
Sanjose S, Foretova L, Maynadie M, Cocco PL, Boffetta P, Brennan P, Chanock SJ,
Browne PV, Lawler M. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and
susceptibility to myeloma. Human Molecular Genetics, 16, (24), 2007, p3117 – 3127.
PMID: 17901044.
* 19 Donohoe G, Morris DW**, Robertson IH, McGhee KA, Murphy K, Kenny N, Clarke
S, Gill M, Corvin AP. DAOA ARG30LYS and verbal memory function in schizophrenia.
Molecular Psychiatry, 12, (9), 2007, p795 – 796. PMID: 17767147.
17
18 Corvin A, McGhee KA, Murphy K, Donohoe G, Nangle JM, Schwaiger S, Kenny N,
Clarke S, Meagher D, Quinn J, Scully P, Baldwin P, Browne D, Walsh C, Waddington JL,
Morris DW, Gill M. Evidence for association and epistasis at the DAOA/G30 and Damino acid oxidase loci in an Irish schizophrenia sample. American Journal of Medical
Genetics Part B: Neuropsychiatric Genetics, 144, (7), 2007, p949 – 953. PMID:
17492767.
17 Donohoe G, Morris D, Clarke S, McGhee K, Schwaiger S, Nangle JM, Robertson I, Gill
M, Corvin A. Variance in facial recognition performance associated with BDNF in
schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric
Genetics, 144B, 2007, p578 – 579. PMID: 17450558.
16 Donohoe G, Morris DW, Clarke S, McGhee K, Schwaiger S, Nangle JM, Garavan H,
Robertson I, Gill M, Corvin A., Variance in neurocognitive performance is associated
with Dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia, 45, 2007,
p454 – 458. PMID: 16930638.
15 Donohoe G, Reilly R, Clarke S, Meredith S, Greene B, Morris D, Gill M, Corvin A,
Garavan H, Robertson I. Do antisaccade deficits in schizophrenia provide evidence of a
specific inhibitory function? Journal of the International Neuropsychological Society,
12, 2006, p901 – 906. PMID: 17064452.
14 Nangle JM, Clarke S, Morris DW, Schwaiger S, McGhee KA, Kenny N, Murphy K, Gill
M, Corvin A, Donohoe G. Neurocognition and suicidal behaviour in an Irish population
with major psychotic disorders. Schizophrenia Research, 85, (1-3), 2006, p196 – 200.
PMID: 16690256.
13 Donohoe G, Clarke S, Morris D, Nangle JM, Schwaiger S, Gill M, Corvin A, Robertson
IH. Are deficits in executive sub-processes simply reflecting more general cognitive
decline in schizophrenia? Schizophrenia Research, 85, 2006, p168 – 173. PMID:
16716568.
12 Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier
DA, Cordeiro Q, Corvin AP, Deshpande S, Egan MF, Ferrell RE, Gill M, Kendler KS, Kirov
G, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, O’Donovan MC, Owen MJ, Sobell JL,
Thelma BK, Vallada H, Weinberger DR, Williams NM, Wood J, Devlin B, and Nimgaonkar
VL. Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based MetaAnalysis of RGS4 Polymorphisms from Thirteen Independent Samples. Biological
Psychiatry, 60, (2), 2006, p152 – 162. PMID: 16631129.
11 Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ,
Preece AC, Dwyer SL, Wilkinson JC, Spurlock G, Kirov G, Buckland P, Waddington JL, Gill
M, Corvin AP, Owen MJ, O’Donovan MC. Evidence that interaction between Neuregulin
1 and its receptor erbB4 increases susceptibility to schizophrenia. American Journal of
Medical Genetics Part B: Neuropsychiatric Genetics, 141, (1), 2006, p96 – 101. PMID:
16249994.
18
* 10 Mutsuddi M, Morris DW**, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. Analysis
of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between
reported common variant associations and schizophrenia. American Journal of Human
Genetics, 79, (5), 2006, p903 – 909. PMID: 17033966.
9 McGhee KA, Morris DW, Schwaiger S, Nangle JM, Donohoe G, Clarke S, Meagher D,
QuinnJ, Scully P, Waddington JL, Gill M, Corvin A. Investigation of the apolipoprotein-L
(APOL) gene family and schizophrenia using a novel DNA pooling strategy for public
database SNPs. Schizophrenia Research, 76, (2-3), 2005, p231 – 238. PMID: 15949655.
8 Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, Norton N,
Williams H, Clement M, Dwyer S, Curran C, Wilkinson J, Moskvina V, Waddington JL, Gill
M, Corvin AP, Zammit S, Kirov G, Owen MJ, O’Donovan MC. Identification in 2
independent samples of a novel schizophrenia risk haplotype of the dystrobrevin
binding protein gene (DTNBP1). Archives of General Psychiatry, 61, (4), 2004, p336 –
344. PMID: 15066891.
* 7 Morris DW, Ivanov D, Robinson L, Williams N, Stevenson J, Owen MJ, Williams J,
O'Donovan MC. Association analysis of two candidate phospholipase genes that map to
the chromosome 15q15.1-15.3 region associated with reading disability. American
Journal Of Medical Genetics Part B (Neuropsychiatric Genetics), 129, (1), 2004, p97 –
103. PMID: 15274049.
* 6 Corvin AP, Morris DW**, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D,
Clair DS, Waddington JL, Gill M. Confirmation and refinement of an 'at-risk' haplotype
for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene
at the Neuregulin-1 locus. Molecular Psychiatry, 9, (2), 2004, p208 – 213. PMID:
14966480.
* 5 Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D,
Waddington JL, Gill M, Corvin AP. Confirming RGS4 as a susceptibility gene for
schizophrenia. American Journal of Medical Genetics (Part B: Neuropsychiatric
Genetics), 125B, (1), 2004, p50 – 53. PMID: 14755443.
* 4 Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Gill M, Corvin
AP. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in
an Irish population-based study. Schizophrenia Research, 60, 2003, p167 – 172. PMID:
12591580.
3 Turic D, Robinson L, Duke M, Morris DW, Webb V, Hamshere M, Milham C, Hopkin E,
Pound K, Fernando S, Grierson A, Easton M, Williams N, Van Den Bree M, Chowdhury R,
Gruen J, Stevenson J, Krawczak M, Owen MJ, O'Donovan MC, Williams J. Linkage
disequilibrium mapping provides further evidence of a gene for reading disability on
chromosome 6p21.3-22. Molecular Psychiatry, 8, (2), 2003, p176 – 185. PMID:
12610650.
19
2 Norton N, Williams NM, Williams HJ, Spurlock G, Kirov G, Morris DW, Hoogendoorn
B, Owen MJ, O'Donovan MC. Universal, robust, highly quantitative SNP allele frequency
measurement in DNA pools. Human Genetics, 110, (5), 2002, p471 – 478. PMID:
12073018.
* 1 Morris DW, Robinson L, Turic D, Duke M, Webb V, Milham C, Hopkin E, Pound K,
Fernando S, Easton M, Hamshere M, Williams N, McGuffin P, Stevenson J, Krawczak M,
Owen MJ, O'Donovan MC, Williams J. Family-based association mapping provides
evidence for a gene for reading disability on chromosome 15q. Human Molecular
Genetics, 22, (9), 2000, p843 – 848. PMID: 10749993.
* Senior author publications as per SFI definition of senior author in 2014.
** Joint first author.
*** I was a member of the analysis committee of the International Schizophrenia
Consortium.
20